−0.015 CAD
−6.34 M CAD
18.43 M CAD
218.98 M
About INNOCAN PHARMA CORPORATION
Sector
CEO
Iris Or Gabi Bincovich
Headquarters
Calgary
Website
Founded
2018
FIGI
BBG00PBK8HG4
InnoCan Pharma Corp. operates as a pharmaceutical tech company. Its segments include: Pharmaceuticals and Consumer Wellness. The Pharmaceuticals segment focuses on developing innovative drug delivery platform technologies based on advanced cannabinoids science. It involves two drug delivery technologies: LPT CBD- loaded liposome platform and CLX CBD-loaded exosomes platform. The Consumer Wellness segment develops and markets a wide portfolio of innovative and self-care products to promote a healthier lifestyle. The company was founded in October 2017 and is headquartered in Alberta, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of INNO is 0.220 CAD — it hasn't changed in the past 24 hours. Watch INNOCAN PHARMA CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange INNOCAN PHARMA CORPORATION stocks are traded under the ticker INNO.
INNO reached its all-time high on Sep 16, 2021 with the price of 1.640 CAD, and its all-time low was 0.130 CAD and was reached on Apr 28, 2020. View more price dynamics on INNO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INNO stock is 0.00% volatile and has beta coefficient of 0.24. Track INNOCAN PHARMA CORPORATION stock price on the chart and check out the list of the most volatile stocks — is INNOCAN PHARMA CORPORATION there?
Today INNOCAN PHARMA CORPORATION has the market capitalization of 63.13 M, it has decreased by −13.04% over the last week.
Yes, you can track INNOCAN PHARMA CORPORATION financials in yearly and quarterly reports right on TradingView.
INNO net income for the last quarter is −395.55 K CAD, while the quarter before that showed 461.11 K CAD of net income which accounts for −185.78% change. Track more INNOCAN PHARMA CORPORATION financial stats to get the full picture.
No, INNO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 12, 2024, the company has 9.00 employees. See our rating of the largest employees — is INNOCAN PHARMA CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOCAN PHARMA CORPORATION EBITDA is −1.59 M CAD, and current EBITDA margin is −27.60%. See more stats in INNOCAN PHARMA CORPORATION financial statements.
Like other stocks, INNO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOCAN PHARMA CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOCAN PHARMA CORPORATION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOCAN PHARMA CORPORATION stock shows the sell signal. See more of INNOCAN PHARMA CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.